Low Glucose Degradation Product Peritoneal Dialysis Regimen Is Associated With Lower Plasma EN-RAGE and HMGB-1 Proinflammatory Ligands of Receptor for Advanced Glycation End Products

Abstract

Biocompatible peritoneal dialysis solutions with low content of glucose degradation products are associated with decreased plasma EN-RAGE and HMGB-1 levels compared to conventional peritoneal dialysis solutions.

Keywords

• glucose degradation products
• peritoneal dialysis
• biokompatibility
• EN-RAGE
• HMGB-1, RAGE